Improving the care of Lassa fever patients: re-evaluating the use of Ribavirin and characterising cardiovascular function

Improving the care of Lassa fever patients: re-evaluating the use of Ribavirin and characterising cardiovascular function

<p>Lassa fever is a viral haemorrhagic fever, endemic to several West African countries. Case fatality rates average 30% across the literature. Ribavirin, a broad-spectrum antiviral agent, has been used to treat Lassa fever for four decades. Ribavirin is a pro-drug, metabolised to its active m...

Szczegółowa specyfikacja

Opis bibliograficzny
1. autor:	Salam, A
Kolejni autorzy:	Horby, P
Format:	Praca dyplomowa
Język:	English
Wydane:	2024
Hasła przedmiotowe:	Lassa fever

Podobne zapisy

Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections
od: Sylvanus Okogbenin, i wsp.
Wydane: (2022-10-01)

Ribavirin for Lassa Fever Postexposure Prophylaxis
od: Christiane M. Hadi, i wsp.
Wydane: (2010-12-01)

Animal Models of Lassa Fever
od: Rachel A. Sattler, i wsp.
Wydane: (2020-03-01)

Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge
od: Qudus Olajide Lawal, i wsp.
Wydane: (2024-07-01)

Bibliometric analysis of global Lassa fever research (1970–2017): a 47 – year study
od: Henshaw Uchechi Okoroiwu, i wsp.
Wydane: (2018-12-01)

Increase in Lassa Fever Cases in Nigeria, January–March 2018
od: Elsie A. Ilori, i wsp.
Wydane: (2019-05-01)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
od: Meirong Wang, i wsp.
Wydane: (2021-03-01)

Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies
od: Hung-Yuan Cheng, i wsp.
Wydane: (2022-08-01)

Lassa fever. Part 1. Etiology, epidemiology and clinical manifestations
od: Elena I. Kazachinskaia, i wsp.
Wydane: (2022-07-01)

Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria
od: Anise N. Happi, i wsp.
Wydane: (2022-08-01)

Risk factors for Lassa fever infection among survivors at the Federal Medical Center, Owo, Ondo State, Nigeria
od: Olayinka Stephen Ilesanmi, i wsp.
Wydane: (2021-06-01)

Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus
od: Anges Yadouleton, i wsp.
Wydane: (2020-01-01)

Lassa fever: History, causes, effects, and reduction strategies
od: Promise Tewogbola, i wsp.
Wydane: (2020-08-01)

A Sporadic and Lethal Lassa Fever Case in Forest Guinea, 2019
od: N’Faly Magassouba, i wsp.
Wydane: (2020-09-01)

Descriptive epidemiology of Lassa fever in Nigeria, 2012-2017
od: Onyebuchi Augustine Okoro, i wsp.
Wydane: (2020-09-01)

Current perspectives on vaccines and therapeutics for Lassa Fever
od: Bryce M. Warner, i wsp.
Wydane: (2024-12-01)

Mastomys natalensis and Lassa Fever, West Africa
od: Emilie Lecompte, i wsp.
Wydane: (2006-12-01)

Molecular confirmation of Lassa fever imported into Ghana
od: Joseph H.K. Bonney, i wsp.
Wydane: (2016-04-01)

Lassa Fever, Nigeria, 2005–2008
od: Deborah U. Ehichioya, i wsp.
Wydane: (2010-06-01)

Advanced Vaccine Candidates for Lassa Fever
od: Igor S. Lukashevich
Wydane: (2012-10-01)

Challenges and Opportunities in Lassa fever Control Efforts in Nigeria
od: Anise N. Happi, i wsp.
Wydane: (2022-10-01)

Assessment of knowledge on Lassa fever disease among caregivers presenting to a tertiary Institution in a Lassa fever endemic region, Southeast Nigeria
od: Maria-lauretta Chito Orji, i wsp.
Wydane: (2022-03-01)

Fatal Case of Lassa Fever, Bangolo District, Côte d’Ivoire, 2015
od: Mathieu Mateo, i wsp.
Wydane: (2019-09-01)

The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria
od: Nnennaya U. Opara, i wsp.
Wydane: (2022-11-01)

Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives
od: Chinyere Aloke, i wsp.
Wydane: (2023-01-01)

COVID-19 and Lassa fever in Nigeria: A deadly alliance?
od: Salihu Sabiu Musa, i wsp.
Wydane: (2022-04-01)

Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
od: Elsie A. Ilori, i wsp.
Wydane: (2019-06-01)

Understanding the transmission pathways of Lassa fever: A mathematical modeling approach
od: Praise-God Uchechukwu Madueme, i wsp.
Wydane: (2023-03-01)

Absence of Nosocomial Transmission of Imported Lassa Fever during Use of Standard Barrier Nursing Methods
od: Anna Grahn, i wsp.
Wydane: (2018-06-01)

Immunogenesis in Lassa fever and prospects for vaccine development
od: Vladimir A. Markin
Wydane: (2023-05-01)

Lassa fever and the Nigerian experience: a review
od: Samuel Ebiojo Amodu, i wsp.
Wydane: (2019-07-01)

Lassa virus protein–protein interactions as mediators of Lassa fever pathogenesis
od: Sharon Jan, i wsp.
Wydane: (2025-02-01)

Lassa fever outbreak in adolescents in North Central Nigeria: report of cases
od: H.O. Akhiwu, i wsp.
Wydane: (2018-10-01)

Lassa fever in West African sub-region: an overview
od: O. Ogbu, i wsp.
Wydane: (2007-01-01)

An overview of Lassa fever
od: Abdulmutalab Musa
Wydane: (2019-10-01)

Recurring Outbreaks of Lassa Fever in Nigeria: Understanding the Root Causes and Strategies for the Future
od: Bashar Haruna Gulumbe, i wsp.
Wydane: (2023-06-01)

A Case Report of Lassa Fever between Boundary Communities in Nigeria and Republic of Benin: A Call for International Collaboration
od: Oladayo David Awoyale, i wsp.
Wydane: (2022-06-01)

A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
od: Kathleen A. Cashman, i wsp.
Wydane: (2017-12-01)

Epidemiological characteristics of Lassa fever cases in Liberia: a retrospective analysis of surveillance data, 2019–2020
od: Ralph Weah Jetoh, i wsp.
Wydane: (2022-09-01)

Household rat infestation and methods of its control in a lassa fever endemic community in Southeast Nigeria
od: Maria-Lauretta Chito Orji, i wsp.
Wydane: (2020-01-01)